Paradigm Biopharmaceuticals |
Market Cap (30-Oct) $153,476,176 (477th) |
Close (30-Jun) $0.99 |
Volume (30-Jun) 1,077,429 |
Shortsold (26-Oct) 593,492 (0.09%) (455th) |
|
52w High $0.435 |
52w Low $0.135 |
P/E 8.12 |
EPS -0.15 |
[ARTICLE] Paradigm Biopharma in $62m cash call
A news article has been posted about Paradigm Biopharmaceuticals on the AFR. The article was published around , on 11 August 2022 at 11:37am.
Listed drug repurposing business Paradigm Biopharmaceuticals has put a big raise to investors, asking them to tip in $62 million while it waits for key trial results.
Read ArticlePAR was $1.99 at the close of trade on 10 August 2022
| Recent Articles about ASX:PAR | |
|---|---|
| 29-Oct | Convening Period for Second Meeting of Creditors Extended to 27 ...
company-announcements.afr.com |
| 24-Oct | Further Obsidian Note Redemption - AFR
company-announcements.afr.com |
| 22-Oct | 2026 Notice of Annual General Meeting - AFR
company-announcements.afr.com |
| 21-Oct | Expiry of PAROB Listed Options – Company in Voluntary ... - AFR
company-announcements.afr.com |
| 21-Oct | Further Obsidian Note Redemption and Phase 3 Data Review Update
company-announcements.afr.com |
| 21-Oct | Appendix 3H - Notification of cessation of securities - AFR
company-announcements.afr.com |
| 21-Oct | 30 September 2026 ASX ANNOUNCEMENT - AFR
company-announcements.afr.com |
| 21-Oct | Market Announcement - AFR
company-announcements.afr.com |
| 16-Oct | PPS Shows Significant Pain Benefit in Rest of World Analysis
company-announcements.afr.com |
| 4-Sep | Paradigm Biopharma Melbourne Investor Lunch Briefing - AFR
company-announcements.afr.com |
| Tracked |
Find all articles about Paradigm Biopharmaceuticals, including others on the AFR, on the media page.
You must be logged in to post a reply.